Cargando…
Drug-Related Problems in Pulmonary Hypertension with Valvular Heart Disease
PURPOSE: The occurrence of drug-related problems (DRPs) and their causes specifically among pulmonary hypertension (PH) with valvular heart disease (VHD) has not been evaluated and is unknown. Therefore, this study aimed to determine the percentage of occurrence, types, and causes of DRPs among PH w...
Autores principales: | Abdul-Ghaffar, Farizan, Md Redzuan, Adyani, Makmor-Bakry, Mohd, Muhamad Nor, Mohamad Arif |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724581/ https://www.ncbi.nlm.nih.gov/pubmed/36483091 http://dx.doi.org/10.2147/TCRM.S374291 |
Ejemplares similares
-
Development and Validation of Adherence Score for Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs
por: Abdul Razak, Salmi, et al.
Publicado: (2020) -
Patient Perspective on Iron Chelation Therapy: Barriers and Facilitators of Medication Adherence
por: Chong, Chia Chee, et al.
Publicado: (2021) -
Adverse Drug Reactions of Antihypertensives and CYP3A5*3 Polymorphism Among Chronic Kidney Disease Patients
por: Lee, Fei Yee, et al.
Publicado: (2022) -
Effects of CYP3A5 Polymorphism on Rapid Progression of Chronic Kidney Disease: A Prospective, Multicentre Study
por: Lee, Fei Yee, et al.
Publicado: (2021) -
Factors associated with lipid goal attainment among acute coronary syndrome patients
por: Mohd-Zulkefli, Siti-Zainora, et al.
Publicado: (2016)